Female-specific pruritus from childhood to postmenopause: Clinical features, hormonal factors, and treatment considerations

Dermatologic Therapy

Volumn 26, Issue 2, 2013, Pages 157-167

  Rimoin, Lauren P ^a   Kwatra, Shawn G ^b   Yosipovitch, Gil ^b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

female itch; itch; pruritus; vulvovaginal itch

Indexed keywords

ANTIFUNGAL AGENT; BENZOCAINE; CLOBETASOL; LANOLIN; NEOMYCIN;

ARTICLE; ATOPIC DERMATITIS; CHILDHOOD; CLINICAL FEATURE; CONTACT DERMATITIS; HORMONE RESPONSE; HUMAN; IRRITANT DERMATITIS; LICHEN SCLEROSUS ET ATROPHICUS; NEURODERMATITIS; PATHOPHYSIOLOGY; PEMPHIGOID GESTATIONIS; POSTMENOPAUSE; PREGNANCY; PRURITUS; PSORIASIS; SQUAMOUS CELL CARCINOMA; TREATMENT CONTRAINDICATION; TREATMENT PLANNING; VAGINA CANDIDIASIS; VULVOVAGINITIS;

ADULT; AGE FACTORS; ANIMALS; CHILD; ESTROGENS; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; POSTMENOPAUSE; PREGNANCY; PREGNANCY COMPLICATIONS; PRURITUS; RECEPTORS, ESTROGEN; VULVAR DISEASES;

EID: 84875850328     PISSN: 13960296     EISSN: 15298019     Source Type: Journal    
DOI: 10.1111/dth.12034     Document Type: Article

References (31)

1. Raine-Fenning NJ, Brincat MP, Muscat-Baron Y,. Skin aging and menopause?: implications for treatment. Am J Clin Dermatol 2003: 4 (6): 371-378.
2. Welsh B, Howard A, Cook K,. Vulval itch. Aust Fam Physician 2004: 33 (7): 505-510.
3. Fischer GO,. Vulval disease in pre-pubertal girls. Australas J Dermatol 2001: 42 (4): 225-234; quiz, 235-236.
4. Poindexter G, Morrell DS,. Anogenital pruritus: lichen sclerosus in children. Pediatr Ann 2007: 36 (12): 785-791.
5. Neill SM, Lewis FM, Tatnall FM, Cox NH,. British Association of Dermatologists' guidelines for the management of lichen sclerosus 2010. Br J Dermatol 2010: 163 (4): 672-682.
6. Pugliese JM, Morey AF, Peterson AC,. Lichen sclerosus: review of the literature and current recommendations for management. J Urol 2007: 178 (6): 2268-2276.
7. Hart WR, Norris HJ, Helwig EB,. Relation of lichen sclerosus et atrophicus of the vulva to development of carcinoma. Obstet Gynecol 1975: 45 (4): 369-377.
8. Wallace HJ,. Lichen sclerosus et atrophicus. Trans St Johns Hosp Dermatol Soc 1971: 57 (1): 9-30.
9. Olson D, Edmonson MB,. Outcomes in children treated for perineal group A beta-hemolytic streptococcal dermatitis. Pediatr Infect Dis J 2011: 30 (11): 933-936.
10. Brabin L, Roberts SA, Fairbrother E, et al. Factors affecting vaginal pH levels among female adolescents attending genitourinary medicine clinics. Sex Transm Infect 2005: 81 (6): 483-487.
11. Keane FE, Ison CA, Taylor-Robinson D,. A longitudinal study of the vaginal flora over a menstrual cycle. Int J STD AIDS 1997: 8 (8): 489-494.
12. Lee SE, Jeong SK, Lee SH,. Protease and protease-activated receptor-2 signaling in the pathogenesis of atopic dermatitis. Yonsei Med J 2010: 51 (6): 808-822.
13. Farage MA, Miller KW, Ledger WJ,. Determining the cause of vulvovaginal symptoms. Obstet Gynecol Surv 2008: 63 (7): 445-464.
14. Xu J, Schwartz K, Bartoces M, Monsur J, Severson RK, Sobel JD,. Effect of antibiotics on vulvovaginal candidiasis: a MetroNet study. J Am Board Fam Med 2008: 21 (4): 261-268.
15. Ahmad A, Khan AU,. Prevalence of Candida species and potential risk factors for vulvovaginal candidiasis in Aligarh, India. Eur J Obstet Gynecol Reprod Biol 2009: 144 (1): 68-71.
16. Pirotta MV, Garland SM,. Genital Candida species detected in samples from women in Melbourne, Australia, before and after treatment with antibiotics. J Clin Microbiol 2006: 44 (9): 3213-3217.
17. Rodriguez MI, Leclair CM,. Benign vulvar dermatoses. Obstet Gynecol Surv 2012: 67 (1): 55-63.
18. Fidel PL Jr, Sobel JD,. Immunopathogenesis of recurrent vulvovaginal candidiasis. Clin Microbiol Rev 1996: 9 (3): 335-348.
19. Cohen AD, Vander T, Medvendovsky E, et al. Neuropathic scrotal pruritus: anogenital pruritus is a symptom of lumbosacral radiculopathy. J Am Acad Dermatol 2005: 52 (1): 61-66.
20. Edwards L,. New concepts in vulvodynia. Am J Obstet Gynecol 2003: 189 (3 Suppl): S24-S30.
21. Meeuwis KAP, Van de Kerkhof PCM, Massuger LFAG, De Hullu JA, Van Rossum MM,. Patients' experience of psoriasis in the genital area. Dermatology (Basel) 2012: 224 (3): 271-276.
22. Van Slobbe AM, Bohnen AM, Bernsen RMD, Koes BW, Bierma-Zeinstra SMA,. Incidence rates and determinants in meralgia paresthetica in general practice. J Neurol 2004: 251 (3): 294-297.
23. Ambros-Rudolph CM, Müllegger RR, Vaughan-Jones SA, Kerl H, Black MM,. The specific dermatoses of pregnancy revisited and reclassified: results of a retrospective two-center study on 505 pregnant patients. J Am Acad Dermatol 2006: 54: 395-404.
24. Kremer AE, Martens JJWW, Kulik W, et al. Lysophosphatidic acid is a potential mediator of cholestatic pruritus. Gastroenterology 2010: 139 (3): 1008-1018, 1018.e1.
25. Oude Elferink RPJ, Kremer AE, Martens JJWW, Beuers UH,. The molecular mechanism of cholestatic pruritus. Dig Dis. 2011: 29 (1): 66-71.
26. Stika CS,. Atrophic vaginitis. Dermatol Ther 2010: 23 (5): 514-522.
27. Wines N, Willsteed E,. Menopause and the skin. Australas J Dermatol 2001: 42 (3): 149-148.
28. Kingston A,. Vulval disease in the postmenopausal patient: a guide to current management. Menopause Int. 2010: 16 (3): 117-120.
29. Cooper SM, Ali I, Baldo M, Wojnarowska F,. The association of lichen sclerosus and erosive lichen planus of the vulva with autoimmune disease: a case-control study. Arch Dermatol 2008: 144 (11): 1432-1435.
30. Ambros-Rudolph CM,. Dermatoses of pregnancy-clues to diagnosis, fetal risk and therapy. Ann Dermatol. 2011: 23 (3): 265-275.
31. Schaefer C, Peters PWJ, Millerk RK,. Drugs during pregnancy and lactation: treatment options and risk assessment, 2nd ed. Amsterdam; Boston: Elsevier Academic Press, 2007.